State Street Global All Cap Equity Ex-U.S. Index Portfolio OCSE:NOVO B Holdings History
State Street Global All Cap Equity ex-U.S. Index Portfolio's Novo Nordisk AS Holding Summary
As of 2025-03-31, State Street Global All Cap Equity ex-U.S. Index Portfolio held 858,565.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr58.65 Mil. This investment constitutes 0.7% of their stock portfolio, and State Street Global All Cap Equity ex-U.S. Index Portfolio now holds 0.02% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2019Q3. And since then State Street Global All Cap Equity ex-U.S. Index Portfolio has made 16 purchases of OCSE:NOVO B, at an average price of kr369.30, for a total of 940,797.00 shares. In addition, there have been 1 sales at an average price of kr187.18 for 82,232.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr451.30, State Street Global All Cap Equity ex-U.S. Index Portfolio's estimated gain on his OCSE:NOVO B holdings is kr55.42 Mil, reflecting a 15.95% gain to date.
State Street Global All Cap Equity ex-U.S. Index Portfolio OCSE:NOVO B (kr451.30) Holding Chart
State Street Global All Cap Equity ex-U.S. Index Portfolio OCSE:NOVO B (kr451.30) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
